Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 2
1(50.0%)
2Total
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07399782Phase 2Not Yet Recruiting

Botulinum Toxin in the Palatopharyngeal Muscle for the Treatment of Obstructive Sleep Apnea

Role: lead

NCT06408363Not ApplicableRecruiting

Effectiveness of Sequential Eustachian Tube Maneuvers in Hyperbaric Oxygen Conditions

Role: lead

NCT00832403Suspended

Gore Tex Implants in the Treatment of Atrophic Rhinitis

Role: lead

All 3 trials loaded